Carpenter Technology Corporation
CRS
$462.01
+0.24%
Carpenter Technology Corporation is a leading manufacturer and supplier of specialty metals, operating within the industrials sector under the metal fabrication industry. The company serves critical end markets including aerospace and defense, medical, energy, and industrial machinery through its two primary segments: Specialty Alloys Operations and Performance Engineered Products. The current investor narrative is heavily focused on the company's strong leverage to the robust aerospace and defense cycle, with recent financial results showing significant margin expansion and profitability recovery from prior cyclical lows. Attention is also centered on the company's ability to capitalize on secular growth trends in next-generation aircraft and medical applications, positioning it as a key beneficiary of industrial and technological demand.…
CRS
Carpenter Technology Corporation
$462.01
Investment Opinion: Should I buy CRS Today?
Rating & Thesis: Hold. CRS is a high-quality operator in a strong cycle, but its extreme valuation after a 90%+ rally prices in perfection, leaving asymmetric risk to the downside. The unanimous bullish analyst sentiment is encouraging but is based on a limited sample of only 2 analysts.
Supporting Evidence: The stock trades at a 36.9x trailing PE and 4.82x PS, a steep premium to the industrials sector. While profitability is excellent (29.99% gross margin, 19.93% ROE) and cash flow is robust ($316.7M TTM FCF), revenue growth has decelerated sequentially to 7.55% YoY. The forward PE of 34.5x offers only a modest discount, implying the market expects growth to continue but not accelerate. The stock trades at 92% of its 52-week high, suggesting limited near-term upside without a fundamental catalyst.
Risks & Conditions: The two biggest risks are valuation compression and cyclical demand peaking. This Hold rating would upgrade to a Buy if the stock experiences a meaningful pullback (e.g., towards $350, representing a ~20% decline) that improves the risk/reward profile, or if quarterly revenue growth re-accelerates above 10% while margins hold. It would downgrade to a Sell if revenue growth turns negative or gross margins contract below 27%. Relative to its history and the likely valuation of its peers, CRS is overvalued, trading on optimistic future expectations rather than current fundamentals.
Sign up to view all
CRS 12-Month Price Forecast
CRS presents a classic 'good company, expensive stock' dilemma. The operational turnaround and leverage to aerospace are compelling, but the 90%+ rally has fully discounted this narrative. The neutral stance reflects the balanced risk/reward at current levels; the upside to new highs (~8%) is limited compared to the potential downside in a bear case (-20% to -50%). The stance would turn bullish on a significant pullback that closes the valuation gap, or if quarterly reports show re-accelerating growth. It would turn bearish if margin trends reverse or the technical uptrend decisively breaks below key support (e.g., $400).
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Carpenter Technology Corporation's 12-month outlook, with a consensus price target around $600.61 and implied upside of +30.0% versus the current price.
Average Target
$600.61
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$370 - $601
Analyst target range
Analyst coverage for CRS is limited, with only 2 analysts providing estimates, indicating this is a smaller-cap stock with less institutional scrutiny which can lead to higher volatility. The consensus sentiment from available institutional ratings is unanimously bullish, with recent actions from firms like BTIG, JP Morgan, and Keybanc maintaining or initiating Buy/Overweight ratings. The average target price implied by earnings estimates is $16.15 per share, but this appears to be an EPS estimate, not a price target; given the lack of explicit price targets in the data, the implied upside cannot be calculated, highlighting the sparse coverage. The wide range between the low EPS estimate of $15.82 and the high of $16.48 suggests some variance in near-term earnings expectations, but the overall tight clustering around the average indicates fundamental agreement on the company's earnings power among the few covering analysts.
Bulls vs Bears: CRS Investment Factors
The investment debate for CRS centers on the tension between its exceptional operational execution within a favorable aerospace cycle and its extreme valuation, which prices in near-perfect execution for years. The bull case, currently supported by stronger evidence from margin expansion, cash flow generation, and technical momentum, argues that CRS is a premium operator deserving of a premium multiple. The bear case warns that the stock's 90%+ run and 36.9x PE ratio have left no room for error. The single most important factor is the sustainability of the aerospace/defense cycle; if demand remains robust, margins hold, and growth re-accelerates, the bull thesis prevails. If the cycle shows signs of peaking or growth decelerates further, the valuation premium will rapidly unwind.
Bullish
- Strong Aerospace & Defense Cycle Leverage: The Aerospace and Defense segment generated $472 million in Q2 FY2026, representing the core growth driver. This aligns with a robust industry cycle for next-generation aircraft, providing a multi-year tailwind for CRS's high-margin specialty metals.
- Dramatic Margin Expansion and Profitability: Gross margin expanded to 29.99% in Q2 FY2026 from 26.22% a year ago, while operating margin reached 21.32%. Net income surged 25% YoY to $105.3 million, demonstrating significant operational improvement and pricing power.
- Powerful Technical Uptrend and Momentum: The stock has gained 90.33% over the past year and is trading near its 52-week high of $475.69. This sustained uptrend, coupled with a 41.66% gain over the prior six months, reflects strong market conviction in the recovery story.
- Healthy Balance Sheet and Strong Cash Flow: The company boasts a strong current ratio of 3.65, a manageable debt-to-equity of 0.39, and generated $316.7 million in TTM free cash flow. This financial strength provides flexibility for growth and resilience against downturns.
Bearish
- Extreme Valuation Premium: CRS trades at a trailing PE of 36.9x and a PS ratio of 4.82x, a significant premium to typical metals manufacturers. This leaves the stock highly vulnerable to multiple compression if earnings growth decelerates or the cycle peaks.
- Revenue Growth Deceleration: Q2 FY2026 revenue of $728 million grew 7.55% YoY, but this follows a quarter with $733.7 million in revenue. This sequential decline suggests potential near-term growth headwinds or demand normalization after a strong run.
- High Volatility and Recent Pullback: With a beta of 1.241, CRS is 24% more volatile than the market. The stock has experienced a -12.76% pullback over the past month and a maximum drawdown of -19.14%, highlighting its susceptibility to sharp corrections.
- Limited Analyst Coverage and Scrutiny: Only 2 analysts provide estimates for CRS, indicating lower institutional visibility. This sparse coverage can exacerbate volatility and makes it harder to gauge consensus expectations, increasing uncertainty for investors.
CRS Technical Analysis
The stock is in a powerful, sustained uptrend, evidenced by a staggering 90.33% gain over the past year. With a current price of $438.32, it is trading at approximately 92% of its 52-week range ($219.58 to $475.69), indicating it is near its cycle highs and demonstrating significant momentum, though also suggesting potential for overextension. Recent momentum shows a deceleration from the torrid yearly pace, with a 3-month gain of 12.47% and a 1-month decline of -12.76%, signaling a healthy consolidation or pullback within the larger uptrend, especially after the stock's 41.66% surge over the prior six months. Key technical support is anchored at the 52-week low of $219.58, while immediate resistance is at the recent high of $475.69; a decisive breakout above this level would confirm the resumption of the primary bull trend. The stock's beta of 1.241 indicates it is approximately 24% more volatile than the broader market (SPY), which is a critical consideration for risk management given its cyclical nature and recent price swings, including a maximum drawdown of -19.14%.
Beta
1.24
1.24x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$228-$476
Price range past year
Annual Return
+95.6%
Cumulative gain past year
| Period | CRS Return | S&P 500 |
|---|---|---|
| 1m | +7.9% | +6.0% |
| 3m | +16.1% | +10.0% |
| 6m | +45.0% | +10.4% |
| 1y | +95.6% | +28.4% |
| ytd | +36.6% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRS Fundamental Analysis
Revenue growth has been solid but shows some sequential deceleration; the most recent quarterly revenue (Q2 FY2026) was $728 million, representing a 7.55% year-over-year increase, though this follows a quarter where revenue was slightly higher at $733.7 million. The Aerospace and Defense segment, contributing $472 million in the latest period, is the clear growth driver, while other segments like Energy ($50.8M) and Medical ($70.7M) provide diversification. Profitability has improved dramatically, with the company reporting net income of $105.3 million and a gross margin of 29.99% in the latest quarter, a significant expansion from the 26.22% gross margin reported in the year-ago quarter (Q2 FY2025) when net income was $84.1 million. The operating margin of 21.32% in Q2 FY2026 further underscores this operational improvement, recovering from a low of 3.90% in Q2 FY2023. The balance sheet is healthy, with a strong current ratio of 3.65 and a moderate debt-to-equity ratio of 0.39, indicating manageable financial leverage. The company is generating robust cash flow, with trailing twelve-month free cash flow of $316.7 million and an ROE of 19.93%, signaling efficient use of equity and an ability to fund operations and growth internally.
Quarterly Revenue
$728000000.0B
2025-12
Revenue YoY Growth
+0.07%
YoY Comparison
Gross Margin
+0.29%
Latest Quarter
Free Cash Flow
$316700000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRS Overvalued?
Given the company's positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE is 36.9x, while the forward PE is 34.5x; the modest discount on the forward multiple suggests the market expects continued, albeit slightly decelerating, earnings growth. Compared to industry averages, the stock trades at a significant premium; its trailing PE of 36.9x and Price-to-Sales (PS) ratio of 4.82x are elevated for a metals manufacturer, but this premium is likely justified by its exposure to high-value aerospace/defense markets, superior margin profile, and strong growth trajectory relative to more commoditized peers. Historically, the current trailing PE of 36.9x sits near the top of its own multi-year range, as seen in the Q2 FY2026 historical ratio of 37.45x, indicating the stock is pricing in very optimistic expectations and may be vulnerable to multiple compression if growth falters or the cycle peaks.
PE
36.9x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -66x~142x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CRS's primary financial risk is its valuation, not its balance sheet. The company's trailing PE of 36.9x and PS of 4.82x represent a massive premium that demands sustained high growth. A deceleration from the current 7.55% YoY revenue growth rate or a contraction from the 29.99% gross margin could trigger significant multiple compression. While the balance sheet is healthy (D/E 0.39), the stock's performance is heavily dependent on continued margin expansion and earnings growth to justify its price, creating earnings volatility risk.
Market & Competitive Risks: The stock faces pronounced market risk from its premium valuation in a cyclical industry. Trading at a PE near the top of its historical range (Q2 FY2026 historical PE of 37.45x), it is highly sensitive to sector rotation away from industrials or growth stocks. Its beta of 1.241 confirms above-market volatility. Competitive risks include potential pricing pressure within the specialty metals space or substitution by newer materials. Furthermore, the stock's 90%+ annual gain makes it susceptible to profit-taking, as evidenced by the recent -12.76% monthly pullback.
Worst-Case Scenario: The worst-case scenario involves a double-hit of cyclical downturn and valuation reset. A recession impacting aerospace and defense demand leads to a 10-15% revenue decline and a 500 basis point gross margin compression. Simultaneously, the market reappraises CRS as a cyclical metals stock, compressing its PE multiple from 36.9x towards the industry average (estimated low-20s). This could realistically drive the stock back towards its 52-week low of $219.58, representing a downside of approximately -50% from the current price of $438.32. The historical max drawdown of -19.14% suggests such a move, while severe, is within the realm of possibility for this volatile stock.
FAQ
The key risks are: 1) Valuation Compression: The primary risk is the high PE of 36.9x compressing if growth slows. 2) Cyclical Downturn: 65% of revenue comes from Aerospace & Defense, a cyclical sector. A downturn would hit earnings hard. 3) Volatility: The stock's beta of 1.241 means it is 24% more volatile than the market, as seen in its -19.14% max drawdown. 4) Execution Misstep: After dramatic margin expansion, any failure to maintain gross margins near 30% would disappoint investors. The valuation risk is currently the most severe given the stock's elevated price.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $400 and $475 as growth normalizes and the premium valuation slightly compresses. The Bull Case (25% probability) targets $475 to $520, requiring re-accelerating growth and sustained high margins. The Bear Case (15% probability) warns of a drop to $220-$350 if the cycle peaks and multiples collapse. The most likely outcome is the Base Case, which assumes the current robust aerospace cycle continues but does not accelerate, leading to range-bound performance at elevated levels.
CRS is overvalued relative to its industry and its own history. With a trailing PE of 36.9x and Price-to-Sales of 4.82x, it trades at a significant premium to most metals manufacturers, which typically have lower multiples. Historically, its current PE is near the top of its range (Q2 FY2026 historical PE of 37.45x). This valuation implies the market expects sustained high growth and margin expansion. If those expectations are met, the stock could hold its premium. If not, a sharp de-rating is likely, making it overvalued on a risk-adjusted basis.
CRS is a good stock for investors who already own it, but a challenging buy at current prices. The company's fundamentals are strong with 29.99% gross margins and 19.93% ROE, but the stock has already rallied 90% in a year and trades at a premium 36.9x PE. The risk/reward is currently balanced to slightly unfavorable, with limited upside to analyst-inferred targets and significant downside risk (-50%) to its 52-week low if the cycle turns. It could be a good buy on a pullback to the $350-$380 range for long-term investors who believe the aerospace cycle has years to run.
CRS is more suitable for a medium-to-long-term investment horizon aligned with the aerospace cycle, not short-term trading. Its high volatility (beta 1.24) and cyclical nature make it risky for short-term holders. The lack of a meaningful dividend (0.29% yield) also negates an income strategy. Given the company is in the midst of a multi-year earnings recovery, investors should have a minimum holding period of 2-3 years to ride out inevitable volatility and capture the full cycle. Short-term traders would be challenged by the stock's sharp swings and current lack of a clear near-term catalyst for further upside.